These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18057525)

  • 1. Markers of angiogenesis in ovarian cancer.
    Merritt WM; Sood AK
    Dis Markers; 2007; 23(5-6):419-31. PubMed ID: 18057525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in epithelian ovarian cancer.
    Bamberger ES; Perrett CW
    Mol Pathol; 2002 Dec; 55(6):348-59. PubMed ID: 12456770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor in ovarian cancer.
    Hazelton DA; Hamilton TC
    Curr Oncol Rep; 1999 Sep; 1(1):59-63. PubMed ID: 11122799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
    Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R
    Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of angiogenesis in epithelial ovarian carcinoma.
    Alvarez AA; Krigman HR; Whitaker RS; Dodge RK; Rodriguez GC
    Clin Cancer Res; 1999 Mar; 5(3):587-91. PubMed ID: 10100710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis Markers in Gynecological Tumors and Patents for Anti-Angiogenic Approach: Review.
    Abdalla DR; Simoens C; Bogers JP; Murta EF; Michelin MA
    Recent Pat Anticancer Drug Discov; 2015; 10(3):298-307. PubMed ID: 26381660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumor microvessel density as a prognostic factor in cancer.
    Weidner N
    Am J Pathol; 1995 Jul; 147(1):9-19. PubMed ID: 7541613
    [No Abstract]   [Full Text] [Related]  

  • 9. Different features of angiogenesis between ovarian and breast carcinoma.
    Nakayama K; Kanzaki A; Takebayashi Y; Toi M; Bando H; Nabei T; Miyazaki K; Fukumoto M
    Cancer Lett; 2001 Sep; 170(2):161-7. PubMed ID: 11463494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer.
    Fujimoto J; Toyoki H; Sakaguchi H; Jahan I; Alam SM; Tamaya T
    Oncol Rep; 2006 Jan; 15(1):21-5. PubMed ID: 16328030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis and molecular target therapy in ovarian carcinomas.
    Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Futakuchi H; Yamaguchi H; Yasuda M; Nishiyama K; Ueki M
    Hum Cell; 2005 Mar; 18(1):1-16. PubMed ID: 16130895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin-1 in neovascularization of ovarian carcinoma.
    Salani D; Di Castro V; Nicotra MR; Rosanò L; Tecce R; Venuti A; Natali PG; Bagnato A
    Am J Pathol; 2000 Nov; 157(5):1537-47. PubMed ID: 11073813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of selected angiogenesis markers and modulators in pre-, peri- and postmenopausal women with ovarian cancer].
    Bednarek W; Mazurek M; Cwiklińska A; Barczyński B
    Ginekol Pol; 2009 Feb; 80(2):93-8. PubMed ID: 19338204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Nestin and CD133 in serous ovarian carcinoma.
    Onisim A; Iancu M; Vlad C; Kubelac P; Fetica B; Fulop A; Achimas-Cadariu A; Achimas-Cadariu P
    J BUON; 2016; 21(5):1168-1175. PubMed ID: 27837619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging biomarkers in ovarian granulosa cell tumors.
    Mills AM; Chinn Z; Rauh LA; Dusenbery AC; Whitehair RM; Saks E; Duska LR
    Int J Gynecol Cancer; 2019 Mar; 29(3):560-565. PubMed ID: 30833441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis and molecular markers in advanced epithelial ovarian cancer: a retrospective study.
    Ferrero A; Dompè D; Ravarino N; Ramella A; Fuso L; Maggiorotto F; Tripodi E; Zola P
    Gynecol Oncol; 2011 Nov; 123(2):301-7. PubMed ID: 21862119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.